OrbitalRX and Micromedex: The future of hospital pharmacy
Tired of evaluating and choosing drug alternatives only to find they aren’t available from your suppliers? Now you can empower your hospital’s pharmacy with the insights and tools necessary to help manage drug shortages with ease. OrbitalRX, now with IBM Micromedex®, combines real-time inventory awareness and clinical decision support capabilities to help hospital pharmacies proactively manage drug shortages and efficiently identify effective alternatives. View the latest evidence-based treatment information, check your hospital’s current drug inventory status, and provide purchasers with a consolidated view of procurement options – all within a single solution.
Benefits
Help improve clinical efficiency
Eliminate the manual work of running reports, analyzing data and transcribing into spreadsheets.
Make informed purchasing decisions
Evaluate drug information, clinical evidence and comparative efficacy alongside your hospital’s drug inventory, purchase history and utilization data.
Support delivery of better care
Inform treatment decisions with the latest evidence-based drug information to support optimal patient care.
Key features
Real-time shortage visibility
Gain full, real-time visibility of drug shortage data across your enterprise, with the ability to drill down to individual campuses.
All-in-one procurement center
Access a single, consolidated view of your procurement options, removing the need to interact with multiple vendors.
Centralized communications center
Improve communication and mitigation strategies, action follow-through and reporting to key stakeholders.
Full shortage management life-cycle administration
Encompass all data, steps and processes within one platform, eliminating the need to interface with multiple one-off applications and systems.
Help mitigate challenges that can impact patient safety
"Patient safety can be compromised by supply chain interruptions, limited drug access due to high medication costs and unforeseen events like COVID-19. OrbitalRX will now help pharmacy managers and buyers mitigate these workflow challenges by identifying drug alternatives from a clinical and supplier perspective.” Adam Orsborn, PharmD MS, Co-founder and CEO, OrbitalRX
Support identification of safe and effective alternatives
“As hospitals across the world experience shortages of life-saving therapies, there is an immediate, critical need for evidence-based information around clinical alternatives that are safe, effective and accessible for patients. By blending our trusted IBM Micromedex content and powerful insights from the OrbitalRX platform, providers and pharmacists will be able to streamline workflows and rapidly respond to drug shortages with appropriate, safe and effective alternative therapies.” Todd Nolen, General Manager, IBM Micromedex solutions, IBM Watson Health®